Discover 1,955 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors
for
Solid Tumors, Adult
Location: Dallas TX
Sponsor: HighField Biopharmaceuticals Corporation
Sex: All
Age: 18 - 70+
Code: NCT05861895
Phase 1, Recruiting
A Study of ASP1002 in Adults for Treatment of Solid Tumors
for
Advanced Solid Tumors
Location: Dallas TX, Iowa City IA, Louisville KY, Saint Paul MN,
Location: Dallas TX, Houston TX, Detroit MI, Silver Spring MD
Sponsor: Bio-Path Holdings, Inc.
Sex: All
Age: 18+
Code: NCT04196257
Phase 1, Recruiting
Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
for
Carcinoma, Squamous Cell
Location: Dallas TX, Houston TX, Little Rock AR, Aurora CO,
Sponsor: Introgen Therapeutics
Sex: All
Age: 18+
Code: NCT00041626
Phase 3, Recruiting
Asciminib Roll-over Study
for
Chronic Myelogenous Leukemia,
Location: Dallas TX, Houston TX, St Louis MO, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 7 - 70+
Code: NCT04877522
Phase 4, Recruiting
Study of STP938 (Dencatistat) in Advanced Solid Tumours
for
Solid Tumor
Location: Dallas TX, San Antonio TX, St. Petersburg FL
Sponsor: Step Pharma, SAS
Sex: All
Age: 18+
Code: NCT06297525
Phase 1, Recruiting
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
for
Advanced HR+/HER2- Breast Cancer
Location: Dallas TX, Kansas City KS, Toronto, New Haven CT
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07604571
Phase 1, Recruiting
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer,
Location: Dallas TX, St Louis MO, Nashville TN, Greenville SC,
Sponsor: Janux Therapeutics
Sex: Male
Age: 18+
Code: NCT07545811
Phase 1, Recruiting
A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.
for
TP53 Y220C Mutation, Advanced Solid Tumors
Location: Dallas TX, San Antonio TX, Nashville TN, Denver CO,
Sponsor: PMV Pharmaceuticals, Inc
Sex: All
Age: 18+
Code: NCT07372625
Phase 1, Recruiting
A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors
for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: NEOK Bio, Inc.
Sex: All
Age: 18+
Code: NCT07612189
Phase 1, Recruiting
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer (mCRPC)